From Name

From Email

To Name

To Email

Message

FDA extends deadline for stem cell clinics to comply with drug development rules

from STAT News

FDA extends deadline for stem cell clinics to comply with drug development rules STAT News The Food and Drug Administration has pushed back by six months the deadline by which clinics that offer stem cell-based treatments must start complying with FDA drug development rules, citing the coronavirus pandemic. READ MORE

more